SUMO2 Antibodies, cDNA Clones Research Reagents

All SUMO2 reagents are produced in house and quality controlled, including 1 SUMO2 Antibody, 60 SUMO2 Gene, 1 SUMO2 IP Kit, 3 SUMO2 qPCR. All SUMO2 reagents are ready to use.

SUMO2 Antibody (1)

    SUMO2 Background

    SUMO2 gene silencing promotes proliferation, and inhibits the apoptosis and senescence of NPCs in rats with IDD through the down-regulation of the p53 signaling pathway. Thus, SUMO2 is a potential target in the treatment of Intervertebral disc degeneration (IDD). The small ubiquitinrelated modifier protein (SUMO) functions as a posttranslational modification system and SUMO2/3 subtypes are often activated in early stress. SUMO2 as a novel activator of Cn-NFAT signaling in cardiomyocytes.

    Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.